Larvol Delta - Essential-Updates-20242025-Surgical-Strategy-for-Esophageal-Cancer-Toward-a-New-Paradigm-in-the-Era-of-Immunotherapy-and-Personalization

Imfinzi (durvalumab) - AstraZeneca

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42495683

Koichi Yagi; Shuichiro Oya; Yoshifumi Baba

Jul 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next